Press Releases

Advanced Search
  • Sep 29, 2015
    Tanto el trabajo como la vida social y familiar se ven afectados por el asma grave; muchos pacientes refieren sentir ansiedad, depresión y aislamiento.

    Boston Scientific ha revelado hoy los resultados de una encuesta exhaustiva, que muestra la verdadera carga y las dificultades diarias a las que se enfrentan las personas con asma en Europa....

  • Sep 28, 2015
    A media briefing with a difference: join us for this interactive session on severe asthma. Hear from Europe’s leading experts in asthma and visit our information stations to bring the story to life.

    September 28, 2015, 18:30 – 20:00 Wyndham Apollo Hotel Amsterdam (15 minutes from the ERS Congress Venue, the Amsterdam RAI Exhibition and Convention Centre) Agenda 18:30 Welcome and scene...

  • Sep 28, 2015
    Work, social and family life all affected by severe asthma, many people report feelings of anxiety, depression and isolation as well

    Boston Scientific today revealed results of a comprehensive survey which shows the true burden of severe asthma and the daily challenges faced by people with asthma in Europe. Uncovering Asthma, a...

  • Sep 28, 2015
    MAJESTIC Trial Data Support Strong Safety Profile with Low Target Lesion Revascularization Rate

    New 12-month clinical trial outcomes assessing the safety and performance of the Boston Scientific (NYSE: BSX) Eluvia™ Drug-Eluting Vascular Stent System reflect a primary patency rate1 of more...

  • Sep 28, 2015
    Schweres Asthma beeinträchtigt Arbeits-, Sozial- und Familienleben, viele Patienten berichten von Angstgefühlen, Depressionen und Isolation.

    Boston Scientific hat heute die Ergebnisse einer umfassenden Umfrage zum tatsächlichen Ausmaß der Belastung durch schweres Asthma und den täglichen Herausforderungen von Asthma-Patienten in...

Show 5102550100 per page
Top